Searched for
BACHUPALLY
Margin revival, Semaglutide launch to drive Dr Reddy’s growth momentum in FY27- Up to 100% hike likely on property registration value in Telangana; even higher hikes in many regions like Kokapet, Gandipet, Mokila, Gachibowli, Gopanpally and others
- USFDA issues Form 483 with 8 observations to Aurobindo's Telangana unit
- No observations by US FDA during plant inspection: DRLDr. Reddy's Laboratories announced that the U.S. Food & Drug Administration (FDA) completed a routine Good Manufacturing Practice (GMP) ins...21 Sep, 2024, 12.14 AM IST
- Dr Reddy's, Sun Pharma recall drugs in US market: USFDADr Reddy's Laboratories and Sun Pharma are recalling products in the US due to manufacturing issues, as per the latest USFDA Enforcement Re...04 Jul, 2024, 08.29 PM IST
- USFDA grants VAI classification to Dr Reddy's R&D centreDr Reddy's Laboratories announced that its Hyderabad-based R&D centre has received Voluntary Action Indicated (VAI) classification from the...12 Feb, 2024, 05.50 PM IST
- Dr Reddy's recalls over 8,000 bottles of generic drug in US due to packaging errorDr Reddy's Laboratories is recalling over 8,000 bottles of Tacrolimus capsules from the US market due to a packaging error. The Hyderabad-b...07 Jan, 2024, 10.43 AM IST
- Dr Reddy's Lab recalls over 4,000 bottles of generic drug in USNew Jersey-based Dr Reddy's Laboratories Inc, a unit of the company, is recalling the affected lot due to "Presence of one Tacrolimus 1 mg ...07 Mar, 2023, 05.13 PM IST
- WEF recognises DRL's Bachupally plant, Cipla's Indore OSD unit as part of Global Lighthouse NetworkA press release from the city-based drug maker said Lighthouses are factories leading the way in Fourth Industrial Revolution (Industry 4.0...11 Oct, 2022, 08.17 PM IST
- Dr Reddy's recalls 1,752 bottles of heartburn drug in the USThe ongoing Class III recall is on account of "Discolouration" and because the product contains brown pellets, USFDA said. As per the US he...10 May, 2020, 01.10 PM IST
- Aurobindo Pharma drops 5% on USFDA observationsShares of Aurobindo Pharma declined to Rs 605.90.14 Jun, 2019, 04.02 PM IST
- Aurobindo Pharma down 5% on receiving USFDA observations"The company will be responding to the USFDA within the stipulated time" said Aurobindo Pharma.06 Jun, 2019, 03.52 PM IST
- Dr Reddy’s trims losses after 30% fall in the dayThe Bachupally observations include four repeat points, including one repeated from 2015 and 2017, said Jefferies.16 Feb, 2019, 10.14 AM IST
- Dr Reddy's Labs rises 4% on receiving EIR for Hyderabad plantThe formulation manufacturing plant-3 Bachupally was issued a form 483 by the USFDA with 11 observations.12 Dec, 2017, 04.35 PM IST
- Dr Reddy's gets 11 observations from USFDA for Hyderabad plantThe audit of our formulations manufacturing plant-3 at Bachupally, Hyderabad by the USFDA has been completed today, said Dr Reddy's Lab.28 Apr, 2017, 09.45 PM IST
- Dr Reddy's recalls 50,000 bottles of Ondansetron tablets in USDr Reddy's Laboratories Inc is recalling 50,280 bottles of Ondansetron tablets 4 mg in a ongoing recall due to "failed impurities/degradati...18 May, 2016, 04.44 PM IST
- Dr Reddy's recalls Rivastigmine Tartrate capsules of 1.5 mg strength from USDr Reddy's Laboratories (DRL) has initiated voluntary recall of Rivastigmine Tartrate Capsules of 1.5 mg strength from the USA market.20 Aug, 2015, 04.17 PM IST
- Dr Reddy's Laboratories recalls anti-seizure, hypertension drugs from US marketThe firm has started recalling Divalproex Sodium extended-release tablets as it has failed dissolution tests.29 Jun, 2015, 01.02 PM IST
- Rajus had 1,100 acres in four villagesRaju entities aggregatively bought a staggering 1,100 acres of land in four villages - Kompally, Pochampally, Bachupally and Jeedimetla - i...06 Feb, 2009, 10.32 AM IST
- Rajus sold land worth Rs 1000 croreMaytas group cos sold nearly 1,90,500 sq yards of land which would have fetched about Rs 213 cr as per the govt rates. Satyam Board meeting...23 Jan, 2009, 11.17 AM IST
Load More
